SEBI Clears The Decks For Duroflex & Four Other IPOs

The primary market momentum continues into 2026 as the Securities and Exchange Board of India (SEBI) cleared five new initial public offerings (IPOs) in the second week of February. These approvals span across diverse sectors including industrial manufacturing, pharmaceuticals, nutraceuticals, infrastructure, and consumer goods. Here is a breakdown of the latest SEBI IPO approvals this week:

latest SEBI IPO approval kissht IPO approval

Duroflex IPO Approval

Duroflex is one of India’s most recognized consumer brands in the mattress and sleep-tech category. The IPO is a mix of a fresh issue (~INR 183 crore) and an offer for sale (2.25 crore shares), managed by JM Financial Institutional Securities. This is one of the most anticipated consumer-sector listings of the year, given the brand’s high retail visibility. Duroflex filed its DRHP on 23 October 2025 and received its observation letter on 12 February 2026.

Lead Manager: JM Financial Institutional Securities.Premier Industrial Corporation IPO Approval
DRHP Filing Date: 23 October 2025
Duroflex IPO Approval Date: 12 February 2026
Issue Type: IPO (Fresh + OFS)

Premier Industrial IPO Approval

Premier Industrial Corporation is a key player in the industrial components and supply chain sector. The company’s IPO is structured as a fresh issue (2.25 cr shares) combined with an Offer for Sale (54 lakh shares). This allows the firm to raise capital for expansion while providing an exit route for existing investors. Managed by Unistone Capital, the company aims to strengthen its balance sheet to support growing demand in the manufacturing sector.

DRHP Filing Date: 30 September 2025
SEBI Approval Date: 10 February 2026
Issue Type: IPO (Fresh + OFS)
Lead Manager: Unistone Capital Private Limited

Virupaksha Organics IPO Approval

Virupaksha Organics, a Hyderabad-based pharmaceutical firm, focuses on Active Pharmaceutical Ingredients (APIs) and specialty intermediates. Notably, this IPO is a “fresh issue only,” indicating that 100% of the funds raised will stay within the company to fuel business growth. Axis Capital Limited is leading the mandate for this listing.

The DRHP was submitted on 7 October 2025, with SEBI granting approval on 12 February 2026. The company plans to use the INR proceeds to commission new manufacturing blocks and enhance its R&D capabilities.

DRHP Filing Date: 7 October 2025
SEBI Approval Date: 12 February 2026
Issue Type: IPO (Fresh Only)
Lead Manager: Axis Capital

Hexagon Nutrition IPO Approval

Hexagon Nutrition is a research-oriented company specializing in clinical nutrition and fortified food products. Unlike its peers this week, Hexagon has opted for an “OFS Only” issue (3.08 crore shares). This serves primarily as a liquidity event for promoters and early investors. The issue is being managed by Cumulative Capital. Having filed its DRHP on 8 October 2025, the company received the SEBI nod on 10 February 2026.

DRHP Filing Date: 08 October 2025
SEBI Approval Date: 10 February 2026
Issue Type: IPO (OFS Only)
Lead Manager: Cumulative Capital

Om Power Transmission IPO Approval

Om Power Transmission operates in the critical infrastructure space, specifically in Engineering, Procurement, and Construction (EPC) for high-voltage power lines. Its IPO consists of both a fresh issue (90 lakh shares) and an offer for sale (10 lakh shares). Beeline Capital Advisors is the coordinating lead manager for the issue. The company filed its draft papers on 9 October 2025 and cleared the regulatory hurdle on 13 February 2026.